Physician profile
Robert L Duerr
NPI 1588611263
$10,870.62
in general payments reported to CMS, 2019-2025
10 companies · $2,971 in 2025
The $2,971 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $505 · 2021: $821 · 2022: $935 · 2023: $1,239 · 2024: $3,536 · 2025: $2,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,233 · Travel and Lodging: $2,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,232.90 |
| Travel and Lodging | $2,513.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,831.02 | 2019-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $3,168.71 | 2022-2025 | Watchman Access System, Versacross Steerable Access Solution, Watchman Flx |
| Abbott Laboratories | $2,201.20 | 2019-2024 | Mitraclip |
| Medtronic, INC. | $450.32 | 2021-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.92 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $52.74 | 2021-2022 | |
| Medtronic Vascular, INC. | $36.19 | 2019-2020 | |
| Irhythm Technologies, INC. | $23.69 | 2021 | |
| Shockwave Medical, INC | $20.76 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $19.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Duerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.